United Therapeutics Q3 Revenue Rises 4% to $832.5M
Q3 2026 revenue was $832.5 million, up 4% year over year from $799.5 million. The company also approved a share repurchase program of up to $2.0 billion through October 21, 2027.
Story updates
11:32:16 AM UTC
SquawkNews
UNITED THERAPEUTICS Q3 REVENUE USD 832.5 MILLION VS. IBES ESTIMATE USD 781.2 MILLION
11:32:36 AM UTC
SquawkNews
*-- Earnings Flash (UTHR) United Therapeutics Reports Q3 Revenue $832.5M, vs. FactSet Est of $781.1M
11:39:37 AM UTC
SquawkNews
United Therapeutics Q3 revenue rises 4%, beats estimates
United Therapeutics' Q3 2026 revenue rose 4% year over year to $832.5M, compared with $799.5M in Q3 2025. The company also approved a new share repurchase program of up to $2.0B through October 21, 2027.Material DetailsContext by AI AnalystThis is a quarterly operating update showing continued reve…